Skip to NavigationSkip to content

News

0
The cost of insulin almost doubled in the United States between 2012 and 2016, according to a report by the non-profit Health Care Cost Institute (...
0
British multinational GlaxoSmithKline (GSK) have acquired US oncology firm Tesaro for $5.1 billion (£4 billion).
0
Britain’s cost effectiveness body NICE has recommended digital Cognitive Behavioural Therapy (CBT) for children with mild depression as a first...
0
The European Commission has chosen to expand the authorised indication for Amgen’s Blincyto (blinatumomab) in the region, it has emerged, approving...

Features

Mesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as we slowly...